Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Alaunos Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 29 | 30 | +1 |
| Shares | 192.1K | 72.1K | −119.9K (−62.4%) |
| Value | $622.8K | $137.0K | −$485.8K (−78.0%) |
New holders (6)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 1,597 | $3.03K | 0.00% |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 21 | $40 | 0.00% |
| Sunbelt Securities, Inc. | 10 | $22 | 0.00% |
| MAI Capital Management | 6 | $12 | 0.00% |
| Sugar Maple Asset Management, LLC | 6 | $11 | 0.00% |
| Royal Bank of Canada | 108 | $0 | 0.00% |
Sold out (5)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| MSD Partners, L.P. | 101,010 | $325.3K |
| Harbour Investments, Inc. | 46 | $148 |
| Chilton Capital Management LLC | 16 | $52 |
| Harbor Investment Advisory, LLC | 2 | $6 |
| Tidemark, LLC | 2 | $6 |